Photo portrait of Miriam Bergeret

Miriam Bergeret, MSc

Articles by Miriam Bergeret, MSc

|4 min read

Single-Cell Phosphoproteomics Can Defeat Drug-Resistant Cancers

Highly multiplexed single-cell phosphoproteomics facilitate combination therapies to treat drug-resistant cancers
|4 min read

CRISPR: The Future of Molecular Diagnostics?

CRISPR-Cas systems can improve the speed, sensitivity, and specificity of diagnostic tests, but are they ready for prime time?
|4 min read

Four Keys to Successful Vaccine Storage

Reliable storage and temperature monitoring are essential to maintain the cold chain and avoid catastrophic vaccine loss
|2 min read

Study Finds Association between Placental Function and Metabolic Disease

The findings may lead to new placental biomarkers and interventions to prevent future metabolic diseases
|1 min read

Spatial Transcriptomics Named Nature’s Method of the Year 2020

The novel method pairs transcriptional data with spatial data to create maps of gene expression within a tissue
|1 min read

Researchers Identify Biomarkers That Predict Survival in Cervical Cancer

The results could help inform treatment decisions, potentially improving survival rates

|2 min read

New Screening System Identifies Genetic Cause of Microcephaly

A new high-throughput screen has identified a genetic cause of a brain disorder associated with Zika virus
|2 min read

Researchers Discover Gene That Helps Cells Destroy Viral Intruders

Demonstrating how human cells “eat” viral invaders, the results could lead to new antivirals
|2 min read

World’s First Mobile iOS-Based DNA Sequence Analyzer

A new mobile app called iGenomics can be used to align and analyze DNA sequences from anywhere in the world
|5 min read

Clinical Applications of Long-Read Sequencing

To overcome the challenges of NGS, researchers have turned to third-generation or long-read sequencing technologies
|2 min read

Latest Data Shows Oxford's COVID-19 Vaccine Is 70.4 Percent Effective

The results are based on two dosing schedules, one of which is 90 percent effective
|1 min read

Early Analysis Finds Moderna's COVID-19 Vaccine Is 94.5 Percent Effective

The vaccine trial reports 95 confirmed cases of COVID-19 with only 5 in the vaccinated group—a statistically significant result
Page 9 of 10